Phoenix Holdings Ltd. Incyte Corp Transaction History

Phoenix Holdings Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$63.34 - $74.11 $852,176 - $997,075	-13,454 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$68.67 - $84.02 $50,609 - $61,922	737 Added 5.8%	13,454 $921,000
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $1.02 Million - $1.11 Million	12,717 New	12,717 $1.08 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.